| 中文名称 |
c-Fms-IN-3
|
| 中文别名 |
4-氰基-N-(4-(4-甲基-1-哌嗪基)-2-(4-甲基-1-哌啶基)苯基)-1H-吡咯-2-甲酰胺;4-氰基-N-[4-(4-甲基-1-哌嗪基)-2-(4-甲基-1-哌啶基)苯基]-1H-吡咯-2-甲酰胺
|
| 英文名称 |
c-Fms-IN-3
|
| 英文别名 |
4-Cyano-N-(4-(4-methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)phenyl)-1H-pyrrole-2-carboxamide;1H-Pyrrole-2-carboxamide, 4-cyano-N-[4-(4-methyl-1-piperazinyl)-2-(4-methyl-1-piperidinyl)phenyl]-;4-CYANO-N-(4-(4-METHYL-1-PIPERAZINYL)-2-(4-METHYL-1-PIPERIDINYL)PHENYL)-1H-PYRROLE-2-CARBOXAMIDE;4-Cyano-N-[4-(4-methyl-1-piperazinyl)-2-(4-methyl-1-piperidinyl)phenyl]-1H-pyrrole-2-carboxamide;4-cyano-N-[4-(4-methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)phenyl]-1H-pyrrole-2-carboxamide;c-FMS inhibitor;c-Fms-IN-3
|
| Cas No. |
885704-21-2
|
| 分子式 |
C23H30N6O
|
| 分子量 |
406.52
|
| 包装储存 |
Powder -20°C 3 years;4°C 2 years
|
| 详情描述 |
c-Fms-IN-3 是c-Fms (CSF1R) 激酶抑制剂,具有抗炎抗风湿活性。
|
| 产品详情 |
c-Fms-IN-3 是c-Fms (CSF1R) 激酶抑制剂,具有抗炎抗风湿活性。
|
| 生物活性 |
c-Fms-IN-3 is a novel c-Fms kinase inhibitor with a potential as anti-inflammatory agent and antirheumatic agent.
|
| 性状 |
Solid
|
| IC50 & Target[1][2] |
c-Fms.
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
Powder -20°C 3 years;4°C 2 years
|
| 参考文献 |
[1]. Meegalla, Sanath K.; Wall, Mark J.; Chen, Jinsheng et al. Structure-based optimization of a potent class of arylamide FMS inhibitors. Bioorganic & Medicinal Chemistry Letters (2008), 18(12), 3632-3637.[2]. Illig, Carl R.; Chen, Jinsheng; Wall, Mark J. et al. Discovery of novel FMS kinase inhibitors as anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters (2008), 18(5), 1642-1648.
|
| 溶解度数据 |
In Vitro: DMSO : 25 mg/mL (61.50 mM; Need ultrasonic)配制储备液
|
[1]. Meegalla, Sanath K.; Wall, Mark J.; Chen, Jinsheng et al. Structure-based optimization of a potent class of arylamide FMS inhibitors. Bioorganic & Medicinal Chemistry Letters (2008), 18(12), 3632-3637.[2]. Illig, Carl R.; Chen, Jinsheng; Wall, Mark J. et al. Discovery of novel FMS kinase inhibitors as anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters (2008), 18(5), 1642-1648.
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。